The Journal of Immunology, Vol 154, Issue 4 1587-1595, Copyright © 1995 by American Association of Immunologists

ARTICLES

Specific unresponsiveness to a retrovirally-transferred class I antigen is controlled through the helper pathway

CC Fraser, M Sykes, RS Lee, DH Sachs and C LeGuern
Transplantation Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Boston 02129.

To investigate the potential role for gene therapy in induction of tolerance to solid organ grafts, we used a murine model based on the introduction of an allogeneic MHC class I gene (H-2Kb) into hematopoietic cells of congenic animals differing only at the class I locus. The H-2Kb gene was placed into a retroviral vector under the control of regulatory sequences of the myeloproliferative sarcoma virus long terminal repeat. Transplantation of H-2Kb retrovirus-transduced autologous bone marrow into B10.AKM (Kk Ik Dq) recipients resulted in detectable levels of H-2Kb RNA and cell surface protein in lymphoid and myeloid lineages. H-2Kb expression was significant, although variable, in bone marrow Mac1+ cells, in splenic B cells, and in CD4+/CD8+ thymocytes 8 wk post-bone marrow transplantation. The recipients of the H-2Kb-transduced bone marrow showed specifically delayed rejection of B10.MBR (Kb Ik Dq) skin grafts disparate only for Kb. However, B10.MBR skin grafts were rapidly rejected when grafted simultaneously with skin grafts from B10 (Kb Ib Db) mice, a strain bearing additional third party alloantigens in association with Kb. Our experiments suggest that the hyporesponsive state induced by using the retrovirally mediated gene transfer model is characterized by the persistence of H-2Kb- specific cytolytic T cell precursors, which may be inactive because of deficient T cell help. Tolerance to Kb induced by this approach may therefore be restricted to T helper cell lineages.

This article has been cited by other articles:

				C. Tian, J. Bagley, and J. Iacomini Expression of Antigen on Mature Lymphocytes Is Required to Induce T Cell Tolerance by Gene Therapy J. Immunol., October 1, 2002; 169(7): 3771 - 3776. [Abstract] [Full Text] [PDF]

				E.-S. Kang and J. Iacomini Induction of Central Deletional T Cell Tolerance by Gene Therapy J. Immunol., August 15, 2002; 169(4): 1930 - 1935. [Abstract] [Full Text] [PDF]

				J. Bagley, C. Tian, D. H. Sachs, and J. Iacomini Induction of T-cell tolerance to an MHC class I alloantigen by gene therapy Blood, May 29, 2002; 99(12): 4394 - 4399. [Abstract] [Full Text] [PDF]

				J. Bagley, Y. Wu, D. H. Sachs, and J. Iacomini Defining the Requirements for Peptide Recognition in Gene Therapy-Induced T Cell Tolerance J. Immunol., November 1, 2000; 165(9): 4842 - 4847. [Abstract] [Full Text] [PDF]

				G. L. Evans and R. A. Morgan Genetic induction of immune tolerance to human clotting factor VIII in a mouse model for hemophilia A PNAS, May 12, 1998; 95(10): 5734 - 5739. [Abstract] [Full Text] [PDF]

				S. Gojo, K. Niwaya, S. Taniguchi, K. Nishizaki, and S. Kitamura Gene Transfer Into the Donor Heart During Cold Preservation for Heart Transplantation Ann. Thorac. Surg., March 1, 1998; 65(3): 647 - 652. [Abstract] [Full Text] [PDF]